MedGene Therapeutics
Silver Spring, US · Maryland corporation
Founders & leadership
TK
Tae-erk KimNamed on SEC filing
JS
James SongNamed on SEC filing
YP
Yonghan ParkNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 2 rounds · 2019–2021
▶$1.1MraisedJun 2021 · 2 investors · BiotechnologyRule 506(b)
▶$1.1MraisedJun 2021 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tae-erk KimDirector
- James SongDirector
- Yonghan ParkExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- First sale
- Jun 2021
- Incorporated
- Corporation, Maryland
- Federal exemptions
- 06b
▶$51.5KraisedOct 2019 · 2 investors · Other Health CareRule 506(b)
▶$51.5KraisedOct 2019 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sean McCrohonExecutive Officer
- Yonghan ParkExecutive Officer, Director
- Offering amount
- $51.5K
- Amount sold
- $51.5K
- Minimum investment
- $1.5K
- First sale
- Aug 2019
- Incorporated
- Corporation, Maryland, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has MedGene Therapeutics raised?
- MedGene Therapeutics has disclosed $1.2M raised across 2 rounds.
- Where is MedGene Therapeutics headquartered?
- MedGene Therapeutics is headquartered in Silver Spring, US.